The tumour immune microenvironment remains poorly characterised in paediatric brain tumours. Here, the authors develop a clinical immune-oncology gene expression assay to profile 1382 paediatric brain tumour samples, and reveal immune profiles and biomarkers that can contribute to diagnosis, prognosis, and treatment response.
- Adrian B. Levine
- Liana Nobre
- Cynthia Hawkins
